14-70522893-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The ENST00000256389.5(ADAM20):c.1865G>A(p.Arg622His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000285 in 1,614,084 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
ENST00000256389.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAM20 | NM_003814.5 | c.1865G>A | p.Arg622His | missense_variant | 2/2 | ENST00000256389.5 | NP_003805.4 | |
ADAM20 | XM_005268151.4 | c.2015G>A | p.Arg672His | missense_variant | 2/2 | XP_005268208.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAM20 | ENST00000256389.5 | c.1865G>A | p.Arg622His | missense_variant | 2/2 | 1 | NM_003814.5 | ENSP00000256389 | P2 | |
ENST00000556646.1 | n.183+24389G>A | intron_variant, non_coding_transcript_variant | 4 | |||||||
ADAM20 | ENST00000652041.1 | c.2015G>A | p.Arg672His | missense_variant | 2/2 | ENSP00000498512 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 250928Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135582
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1461788Hom.: 0 Cov.: 32 AF XY: 0.0000261 AC XY: 19AN XY: 727202
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152296Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74466
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at